Welcome to the California Cancer Registry
NAACCR 2007 Gold Certification

Web Query Tool

Web Query Tool

Generate customized maps and tables of California cancer incidence or mortality rates.

Quick Links for More Information on Meaningful Use



Meaningful Use : Cancer Reporting in California

The California Department of Public Health (CDPH) is coordinating all reporting for Meaningful Use (MU) for California. CDPH is utilizing a Health Information Exchange (HIE) Gateway to receive and process MU files.  For more information on the CDPH HIE Gateway, please go to http://hie.cdph.ca.gov.

To participate in MU for Cancer Reporting providers cancer data must meet the HL7 Clinical Document Architecture (CDA) 2.0 standard, and the messages must conform to the CDA implementation specifications found in the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries.  and the technology used by the providers to generate the HL7 CDA .XML message has to be listed on the Certified Health IT Product List (CHPL) for cancer data reporting.

There are two transmission options for submitting MU data for Cancer Reporting:

  • File Upload via Hypertext Transfer Protocol Secure (HTTPS) – CCR
  • Secure File Transfer Protocol (SFTP)

If you do not know your transport method, please ask your information technology representative or your Electronic Health Record (EHR) vendor prior to enrolling to submit MU cancer data. 


Onboarding Process

Instructions for Enrolling in MU Cancer Reporting

Step 1

Open the following URL in your web browser:

Step 2

Follow the on-screen directions to Create a New Account and Click Create Account.


  • A "Thank you" screen will appear that references the email mentioned below.

Step 3

You will receive an email from HIEHelp@cdph.ca.gov, similar to the image below, requesting confirmation of your registration.



Step 4

Click on the link in the email to confirm your registration.


Step 5

Enroll for Cancer Reporting




Step 6

You will be redirected to the Log In page.

Step 7

The screen below is then displayed:


  • At a minimum, please complete the required fields marked with an asterisk and then Click Submit.

  • You are then directed to the Manage Submissions page:



Step 8

On the Manage Submissions screen, Click Enroll for the California Cancer Registry.

  • You are then directed to the CCR Supplemental Data page. Answer the questions and Click Submit.



  • The following screen appears:



Step 9

Next, you will receive an email from CDPH HIE Gateway, letting you know that you have successfully enrolled with CCR and providing you directions and options for transmitting your data.




Now that you are Registered and Enrolled with the CDPH HIE Gateway, you are ready to make the decision how you want to submit your MU cancer data. There are two options available to you that will allow the data to go directly to the CCR.

  1. Hypertext Transfer Protocol Secure (HTTPS): Go to https://transfer.ccr.ca.gov/ and follow the directions provided. (This is the easiest and preferred transmission message.)

  2. Secure File Transfer Protocol (SFTP): Click here for instructions here

Once you have selected your transmission option, you are able to submit HL7 CDA .XML files to the Cancer Registry. For the Testing & Validation phase, you are asked to submit 5 test messages that pass the CDC Validation process. Once your office has achieved this, you will then be moved to Production for ongoing data submission.


Ongoing Data Submission

You can begin ongoing data submission in compliance with MU for Cancer Reporting. While actively engaged in the steps above, you will be receiving emails and possibly telephone calls from CDPH HIE and CCR. You should maintain copies of these communications for EHR Incentive Program audit purposes.

If you have any questions regarding these processes, you can contact our office at MU2CCRHelp@ccr.ca.gov



MU2 Skin Cancer Reporting Requirements

Cancer Reporting Requirements:

Dermatologists are required by law to report all new cases of melanoma to their regional cancer registry.

Please Note:  This reporting requirement is separate from the Medicare Physician Quality Reporting System (PQRS), and is mandated by California Health and Safety Code, Section 103885 and California Code of Regulations, Section 2593. These laws require that all cases of melanoma be reported to CCR when diagnosed by a health care provider, laboratory, or hospital. Required reporting enables California to identify disease trends, track disease outbreaks, and aid in preventive measures.

To report new cases of melanoma use the following form:

Below are the MU2 requirements for skin cancers.   This information is in California’s Volume I., Section II.1.4 – II.1.4.1-II.1.4.2

Reportable Skin Cancers Include:

  • Skin cancers in the genital sites (any histology) (vagina (C52.9); clitoris (C51.2); labium (C51.0); vulva (C51.9); prepuce (C60.0); penis (C60.9) and scrotum (C63.2) are reportable.
  • Malignant tumors of the skin such as
    • adnexal carcinomas (e.g., carcinomas of the sweat gland,
    • sebaceous gland,
    • ceruminous gland, and hair follicle,
    • adenocarcinomas,
    • lymphomas,
    • melanomas including the following
      • Early melanoma insitu*
      • Evolving melanoma insitu*                        
    • sarcomas
    • Merkel cell tumors
    • Any carcinoma arising in a hemorrhoid is reportable since hemorrhoids arise in mucosa, not in the skin.

Non-Reportable to the Cancer Registry:

  • Basal cell carcinomas of the skin
  • Epithelial carcinomas of the skin
  • Papillary carcinomas of the skin
  • Squamous cell carcinomas of the skin
  • Early Melanoma 
  • Evolving Melanoma  

NOTE:  The term “insitumust be included in diagnosis in order for early and evolving melanoma insitu to be reportable



HIE Gateway Help

Cancer Specific Support

Steven Starr: Steven.Starr@cdph.ca.gov

Maggie Burgos: Maggie.Burgos@cdph.ca.gov